CNS Pharmaceuticals Financial Overview
CNS Pharmaceuticals's market cap is currently $3.85M. The company's EPS TTM is $-5.76; its P/E ratio is -0.11; CNS Pharmaceuticals is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
